{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:47:16Z","timestamp":1777466836904,"version":"3.51.4"},"reference-count":35,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BST"],"published-print":{"date-parts":[[2021,8,31]]},"DOI":"10.5582\/bst.2021.01194","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T18:06:48Z","timestamp":1626286008000},"page":"219-230","source":"Crossref","is-referenced-by-count":14,"title":["The impact of COVID-19 pandemic on the utilization of ambulatory care for patients with chronic neurological diseases in Japan: Evaluation of an administrative claims database"],"prefix":"10.5582","volume":"15","author":[{"given":"Kenichiro","family":"Sato","sequence":"first","affiliation":[{"name":"Department of Neuropathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan."},{"name":"Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Mano","sequence":"additional","affiliation":[{"name":"Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Niimi","sequence":"additional","affiliation":[{"name":"Unit for Early and Exploratory Clinical Development, The University of Tokyo Hospital, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Geriatric Center Hospital, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsushi","family":"Toda","sequence":"additional","affiliation":[{"name":"Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Iwatsubo","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan."},{"name":"Unit for Early and Exploratory Clinical Development, The University of Tokyo Hospital, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Katayama Y, Kiyohara K, Kitamura T, Hayashida S, Shimazu T. Influence of the COVID-19 pandemic on an emergency medical service system: A population-based, descriptive study in Osaka, Japan. Acute Med Surg. 2020; 7:e534.","DOI":"10.1002\/ams2.534"},{"key":"2","unstructured":"2. Ministry of Health, Labor and Welfare. Avoid the &quot;Three Cs&quot;. <i>https:\/\/www.mhlw.go.jp\/content\/3CS.pdf<\/i> (accessed April 2, 2021)."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Sud A, Torr B, Jones ME, <i>et al.<\/i> Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: A modelling study. Lancet Oncol. 2020; 21:10355-1044.","DOI":"10.1016\/S1470-2045(20)30392-2"},{"key":"4","unstructured":"4. Japan Medical Association. Questionnaire survey on the status of medical practice management under the new coronavirus. <i>https:\/\/www.med.or.jp\/dl-med\/teireikaiken\/20200610_6.pdf<\/i> (accessed April 2, 2021)."},{"key":"5","unstructured":"5. Ministry of Health, Labor and Welfare. Temporary measures for medical reimbursement for new coronavirus infections. (<i>https:\/\/www.mhlw.go.jp\/content\/000602230.pdf<\/i> (accessed April 2, 2021). (in Japanese)"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Bloem BR, Dorsey ER, Okun MS. The coronavirus disease 2019 crisis as catalyst for telemedicine for chronic neurological disorders. JAMA Neurol. 2020; 77:927-928.","DOI":"10.1001\/jamaneurol.2020.1452"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Looi MK. Covid-19: Japan declares state of emergency as Tokyo cases soar. BMJ. 2020 Apr 9; 369:m1447.","DOI":"10.1136\/bmj.m1447"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Wosik J, Clowse MEB, Overton R, Adagarla B, Economou-Zavlanos N, Cavalier J, Henao R, Piccini JP, Thomas L, Pencina MJ, Pagidipati NJ. Impact of the COVID-19 pandemic on patterns of outpatient cardiovascular care. Am Heart J. 2021 Jan;231:1-5. doi: 10.1016\/j.ahj.2020.10.074. Epub 2020 Nov 1. PMID: 33137309; PMCID: PMC7604084.","DOI":"10.1016\/j.ahj.2020.10.074"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Saliba-Gustafsson EA, Miller-Kuhlmann R, Kling SMR, Garvert DW, Brown-Johnson CG, Lestoquoy AS, Verano MR, Yang L, Falco-Walter J, Shaw JG, Asch SM, Gold CA, Winget M. Rapid implementation of video visits in neurology during COVID-19: Mixed methods evaluation. J Med Internet Res. 2020; 22:e24328.","DOI":"10.2196\/24328"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yang L, Brown-Johnson CG, Miller-Kuhlmann R, Kling SMR, Saliba-Gustafsson EA, Shaw JG, Gold CA, Winget M. Accelerated launch of video visits in ambulatory neurology during COVID-19: Key lessons from the Stanford experience. Neurology. 2020; 95:305-311.","DOI":"10.1212\/WNL.0000000000010015"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. French JA, Brodie MJ, Caraballo R, <i>et al.<\/i> Keeping people with epilepsy safe during the COVID-19 pandemic. Neurology. 2020; 94:1032-1037.","DOI":"10.1212\/WNL.0000000000009632"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Reeves JJ, Ayers JW, Longhurst CA. Telehealth in the COVID-19 era: A balancing act to avoid harm. J Med Internet Res. 2021; 23:e24785.","DOI":"10.2196\/24785"},{"key":"13","unstructured":"13. Ministry of Health, Labor and Welfare. Study group on the review of guidelines for the appropriate implementation of online medical treatment. <i>https:\/\/www.mhlw.go.jp\/stf\/shingi\/other-isei_513005_00001.html<\/i> (accessed April 2, 2021). (in Japanese)"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Whaley CM, Pera MF, Cantor J, Chang J, Velasco J, Hagg HK, Sood N, Bravata DM. Changes in health services use among commercially insured US populations during the COVID-19 pandemic. JAMA Netw Open. 2020; 3:e2024984.","DOI":"10.1001\/jamanetworkopen.2020.24984"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Zhao J, Wang Y, Fisher M, Liu R. Slower recovery of outpatient clinics than inpatient services for stroke and other neurological diseases after COVID-19 pandemic. CNS Neurosci Ther. 2020; 26:1322-1326.","DOI":"10.1111\/cns.13459"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Sakata N, Okumura Y. Thyroid function tests before prescribing anti-dementia drugs: A retrospective observational study. before press. Clin Interv Aging. 2018; 13:1219-1223.","DOI":"10.2147\/CIA.S168182"},{"key":"17","unstructured":"17. Ministry of Health, Labor and Welfare. An outline of the Japanese medical system. <i>https:\/\/www.mhlw.go.jp\/english\/policy\/health-medical\/health-insurance\/index.html<\/i> (Accessed April 2, 2021)."},{"key":"18","unstructured":"18. Takemura S. Sone T. Research and development on intractable &amp; rare diseases in Japan: Contribution of the National Institute of Public Health to research program management. Journal of the National Institute of Public Health. 2019; 68:45-54."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Nakaoka S, Ishizaki T, Urushihara H, Satoh T, Ikeda S, Yamamoto M, Nakayama T. Prescribing pattern of anti-Parkinson drugs in Japan: A trend analysis from 2005 to 2010. PLoS One. 2014; 9:e99021.","DOI":"10.1371\/journal.pone.0099021"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Suzuki M, Arai M, Hayashi A, Ogino M. Adherence to treatment guideline recommendations for Parkinson&apos;s disease in Japan: A longitudinal analysis of a nationwide medical claims database between 2008 and 2016. PLoS One. 2020; 15:e0230213.","DOI":"10.1371\/journal.pone.0230213"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Fonferko-Shadrach B, Lacey AS, White CP, Powell HWR, Sawhney IMS, Lyons RA, Smith PEM, Kerr MP, Rees MI, Pickrell WO. Validating epilepsy diagnoses in routinely collected data. Seizure. 2017; 52:195-198.","DOI":"10.1016\/j.seizure.2017.10.008"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Moura LM, Price M, Cole AJ, Hoch DB, Hsu J. Accuracy of claims-based algorithms for epilepsy research: Revealing the unseen performance of claims-based studies. Epilepsia. 2017; 58:683-691.","DOI":"10.1111\/epi.13691"},{"key":"23","unstructured":"23. Aragon TJ 2020. epitools: Epidemiology Tools. R package version 0.5-10.1. <i>https:\/\/CRAN.R-project.org\/package=epitools<\/i> (accessed April 2, 2021)."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Balduzzi S, R\u00fccker G, Schwarzer G. How to perform a meta-analysis with R: A practical tutorial. Evid Based Ment Health. 2019; 22:153-160.","DOI":"10.1136\/ebmental-2019-300117"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kurita N. Association of the Great East Japan Earthquake and the Daiichi nuclear disaster in Fukushima City, Japan, with birth rates. JAMA Netw Open. 2019; 2:e187455.","DOI":"10.1001\/jamanetworkopen.2018.7455"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Harada S, Uno S, Ando T, <i>et al.<\/i> Control of a nosocomial outbreak of COVID-19 in a university hospital. Open Forum Infect Dis. 2020; 7:ofaa512.","DOI":"10.1093\/ofid\/ofaa512"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Sato K, Mano T, Iwata A, Toda T. Neuropsychiatric adverse events of chloroquine: A real-world pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database. BioSci Trends. 2020; 14:139-143.","DOI":"10.5582\/bst.2020.03082"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Bates D, M\u00e4chler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015; 67:1-48.","DOI":"10.18637\/jss.v067.i01"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Xiao H, Dai X, Bradley H. Wagenaar BH, Liu F, Augusto O, Guo Y, Unger JM. The impact of the COVID-19 pandemic on health services utilization in China: Time-series analyses for 2016-2020. Lancet Reg Health West Pac. 2021; 9:1-10.","DOI":"10.1016\/j.lanwpc.2021.100122"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Bruine de Bruin W. Age differences in COVID-19 risk perceptions and mental health: Evidence from a national U.S. survey conducted in March 2020. J Gerontol B Psychol Sci Soc Sci. 2021; 76:e24-e29.","DOI":"10.1093\/geronb\/gbaa074"},{"key":"31","unstructured":"31. Al-Chalabi M, Alshaer Q, Zakarna L, Robertson J, Manousakis G, Ghannam M. The Impact of Coronavirus Disease-2019 on Outpatient Neurology. J Neurol Neurosci. 2020; 11:327."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Szperka CL, Ailani J, Barmherzig R, Klein BC, Minen MT, Halker Singh RB, Shapiro RE. Migraine care in the era of COVID-19: Clinical pearls and plea to insurers. Headache. 2020; 60:833-842.","DOI":"10.1111\/head.13810"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Kelman L. Migraine changes with age: IMPACT on migraine classification. Headache. 2006; 46:1161-1171.","DOI":"10.1111\/j.1526-4610.2006.00444.x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Assenza G, Lanzone J, Brigo F, Coppola A, Di Gennaro G, Di Lazzaro V, Ricci L, Romigi A, Tombini M, Mecarelli O. Epilepsy care in the time of COVID-19 pandemic in Italy: Risk factors for seizure worsening. Front Neurol. 2020; 11:737.","DOI":"10.3389\/fneur.2020.00737"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Zebenholzer K, Gall W, W\u00f6ber C. Use and overuse of triptans in Austria - a survey based on nationwide healthcare claims data. J Headache Pain. 2018; 19:34.","DOI":"10.1186\/s10194-018-0864-0"}],"container-title":["BioScience Trends"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/15\/4\/15_2021.01194\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T01:25:40Z","timestamp":1715131540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/15\/4\/15_2021.01194\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,31]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.5582\/bst.2021.01194","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.05.10.21256951","asserted-by":"object"}]},"ISSN":["1881-7815","1881-7823"],"issn-type":[{"value":"1881-7815","type":"print"},{"value":"1881-7823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,31]]},"article-number":"2021.01194"}}